TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Lower extremity motor scores according to ASIA examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking Index for SCI - II (WISCI-II)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ka parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vd parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cl/F parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ctau parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in child behavior checklist
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Responder Rate at 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Treatment Related Serious Adverse Events at 3 months
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Right Ventricular (RV) Ejection Fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Right Ventricular (RV) Lipid Content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in skeletal muscle lipid content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of severe oral mucositis (grade 3+)
Endpoint domain: Adverse events/effects
Primary endpoint: Time to first request for pain reliever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse reactions to magnesium sulfate
Endpoint domain: Adverse events/effects
Primary endpoint: Percent change from baseline in BMD at lumbar spine (L1-L4) in women with uterine fibroids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change from baseline in BMD at lumbar spine (L1-L4) in women with endometriosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of mortality at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Risk of mortality at 5 years
Endpoint domain: Mortality/survival
Primary endpoint: Difference between predicted and measured plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortisol level response to sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Thyroid function response to sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidence of study drug emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of physical symptoms of post intensive care syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of cognitive symptoms of post intensive care syndrome
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Presence of psychological symptoms of post intensive care syndrome
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in infant skin temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Serum ATX level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-metre Walking Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight Bearing Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of WOMAC Score Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of VAS Score (patient pain intensity) Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The International Knee Documentation Committee score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Knee injury and Osteoarthritis Outcome Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Modified Lysholm scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Anterior Cruciate Ligament OsteoArthritis Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: American Orthopaedic Foot and Ankle Society, Ankle-Hindfoot Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Effect on medical diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incident Heart Failure
Endpoint domain: Mortality/survival
Primary endpoint: Chest drain insertion success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: PTSD for adolescents
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Generalized anxiety disorder
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Measures of organ dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Borderline Symptoms List 23 (BSL-23)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Children's Functional Independence Measure (WeeFIM)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: facial nerve thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Presence of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Sedentary Time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from baseline in morning serum cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Neurodevelopmental assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deep Sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: REM Sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Time to Sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: PROMIS Sleep Disturbance Score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Oral Health-Related Quality of Life (OHRQoL) changes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of patients with at least one Trastuzumab deruxtecan related Adverse Drug Reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Tolerability via Post-Procedure Tolerability Survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Difference in Biomarkers between Control and BE/EAC patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Up and Go Dual Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in psychosocial well-being
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Decrease in unmet needs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Frailty level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence and severity of discoloration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in LVOT gradient/midventricular gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Presence of postoperative nausea and/or vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: intensity, extent and characteristics of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance to 900 mg protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of localized adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Change in body weight (%) from baseline week 0 to week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of participants who achieved body weight reduction >= 5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of shoulder injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Contrast use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of clinically-successful hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Grading of Carpal Tunnel Syndrome (CTS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of Endometriosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Distress Thermometer Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of severe depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Motor assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Identified proteins' variation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental Stress Index/Short Form (PSI/SF)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mindful Attention Awareness Scale (MAAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tacrolimus concentration levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sufficient SpO2 oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Seizure detection yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Development of post-TIPS overt HE
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended Dose for Expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of revision TKA
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of Next-Generation ID-Cap System
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Estimation of the immune activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quantities of vaginal microflore bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Solicited local and systemic reactions through Day 7 after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Unsolicited local and systemic adverse events (AEs) through the end of the study
Endpoint domain: Adverse events/effects
Primary endpoint: Serious adverse events (SAEs) through the end of the study
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse events of special interest (AESI) through the end of the study
Endpoint domain: Adverse events/effects
Primary endpoint: Outcome of mother
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in HbA1c from Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time in Therapy range
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Blockade level after caudal anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum effective concentration of ropivacaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of 4th degree neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pain during pulpal treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of the ambassador program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of the ambassador program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum pepsinogen indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Histopathologic OLGA and OLGIM staging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Primary Diagnosis given after primary workup
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Movement Screen Test Protocol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vemp response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Distribution of knee isokinetic angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Markers of Metabolic Syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Markers of Stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child Mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adherence with Pacemaker Care Practices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Study Participants Recruited
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Study Participants With Complete Study Data Captured
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Serotonin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Value of PEEP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Harris Mat for Plantar Pressure Distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pain Coping Strategies
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Serum lactate measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SRI response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3 and 4 laboratory abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: plasma fibrinogen level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pregnancy Detection Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Wrist extensors manual muscle test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Wrist ROMS through Goniometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Spasticity through modified Ashworth scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Upper extremity functional index (UEFI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Students' performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Interictal epileptiform discharges (IEDs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Spectral features
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Self-reported intervention adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Concentration of cord blood phosphate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decrease in adolescent birth rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Decrease in proportion of adolescents who have ever been pregnant or caused a pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Increase in adolescent modern contraceptive prevalence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Occurrence of major access site vascular complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Hemostasis success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Eligible Participants Who Agreed to be Enrolled in the Study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total Number of Participants Who Demonstrated Acceptability (Intervention Arm ONLY)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Condom Use Among Participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of AI-Driven Sepsis Prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in daily average VAS score for overall breast pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Regulatory emotional self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of AEs leading to discontinuation of study treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Pain Intensity Postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interleukin-6 (IL-6) Levels Postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamics of serum NFL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Lung Function (FEV1 change from baseline)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Th17 proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Capability, opportunity and motivation of nurses
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Joint Range changes (CFROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pelvic Misalignments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best Distance Spectacle Corrected Visual Acuity (BDSCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective numeric scale related to several ocular symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 3-year local recurrence-free survival (LRFS)
Endpoint domain: Mortality/survival
Primary endpoint: Change from Baseline in perceived effort on the Borg category-ratio 10-point scale (CR 10)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline in respiratory rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants with Local and Systemic Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Participants' experience using the intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in TETRAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of ICU stays
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Best Spectacle-Corrected Distance Visual Acuity (BSCDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 14-day all cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: neck functional activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of sarcopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent time spent in hyperglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Psychosocial health quality of life score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: cure rate at 16 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Salivary cortisol awakening response (CAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of participants who deliver before 34 weeks gestation
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of children with Inactive or Minimally Active Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bench press repetitions to failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee extensions repetitions to failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incorporation rate of extracellular vesicles into platelet-rich plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Treatment related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Visual analogue scale (VAS) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle strength change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accessibility to the fracture site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: esthetic appearance and scarring
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: radiographic verification of adequacy of fracture reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes